0001213900-23-060531.txt : 20230728
0001213900-23-060531.hdr.sgml : 20230728
20230728121300
ACCESSION NUMBER: 0001213900-23-060531
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230728
DATE AS OF CHANGE: 20230728
EFFECTIVENESS DATE: 20230728
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytogel Pharma, LLC
CENTRAL INDEX KEY: 0001491841
IRS NUMBER: 000000000
STATE OF INCORPORATION: CT
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-488181
FILM NUMBER: 231121573
BUSINESS ADDRESS:
STREET 1: 3 THORNDAL CIRCLE
CITY: DARIEN
STATE: CT
ZIP: 06820
BUSINESS PHONE: 203-966-9867
MAIL ADDRESS:
STREET 1: 3 THORNDAL CIRCLE
CITY: DARIEN
STATE: CT
ZIP: 06820
D
1
primary_doc.xml
X0708
D
LIVE
0001491841
Cytogel Pharma, LLC
3 THORNDAL CIRCLE
DARIEN
CT
CONNECTICUT
06820
203-966-9867
CONNECTICUT
Cytogel Surviving Entity, LLC
Cytogel, LLC
None
Limited Liability Company
true
C.
Dean
Maglaris
84 Beacon Hill Lane
New Canaan
CT
CONNECTICUT
06840
Executive Officer
Director
The issuer is an LLC; the "director" function is fulfilled by Managers.
Jerry
P.
Leamon
280 Cognewaugh Road
Cos Cob
CT
CONNECTICUT
06807
Director
The issuer is an LLC; the "director" function is fulfilled by Managers.
Cassandra
Klimp
46 Station Street
Southport
CT
CONNECTICUT
06890
Director
The issuer is an LLC; the "director" function is fulfilled by Managers.
Frederick
W.
Telling
2068 Country Club Drive
Port Orange
FL
FLORIDA
32128
Executive Officer
Director
The issuer is an LLC; the "director" function is fulfilled by Managers.
Steven
Chrust
107 Saddle Rock Road
Stamford
CT
CONNECTICUT
06902
Director
The issuer is an LLC; the "director" function is fulfilled by Managers.
Theodore
Maione
c/o Cytogel Pharma, LLC
333 Broadway, Suite 420
Troy
NY
NEW YORK
12180
Executive Officer
Dr. Maione is the Issuer's Chief Scientific Officer.
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-06-10
false
true
true
false
0
2193276
1653884
539392
The Total Offering Amount and Total Amount Sold includes the value of securities issued pursuant to the exchange of outstanding promissory notes for the offered securities.
false
15
0
true
0
true
0
true
false
Cytogel Pharma, LLC
/s/ C. Dean Maglaris
C. Dean Maglaris
Chief Executive Officer
2023-07-28